earnings
PR
NASDAQ · PROK
ProKidney Corp.
Healthcare · Biotechnology
$1.30
Down-$0.18 (-11.90%)
Updated Nov 1, 2026, 4:43 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 623.32M
- P/E ratio
- -4
- Dividend yield
- 0.00%
- 52-week range
- $1.29 – $3.27
- Volume
- 1.73M
- Avg. volume
- 1.98M
Price performance · PROK
PROK price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
PROK closed at $1.30 after 20 trading sessions, down 18.04% for the selected period.
- Last close
- $1.30
- Period change
- -18.04%
- Period low
- $1.30
- Period high
- $1.74
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $1.41 | $1.4594 | $1.29 | $1.295 | 1.73M |
| Oct 29, 2026 | $1.51 | $1.53 | $1.43 | $1.47 | 821.23K |
| Oct 28, 2026 | $1.47 | $1.595 | $1.46 | $1.52 | 1.5M |
| Oct 27, 2026 | $1.39 | $1.55 | $1.355 | $1.515 | 1.37M |
| Oct 26, 2026 | $1.41 | $1.435 | $1.35 | $1.36 | 761.68K |
| Oct 23, 2026 | $1.43 | $1.44 | $1.37 | $1.41 | 535.23K |
| Oct 22, 2026 | $1.42 | $1.48 | $1.415 | $1.43 | 584.48K |
| Oct 21, 2026 | $1.44 | $1.49 | $1.44 | $1.44 | 601.29K |
| Oct 20, 2026 | $1.40 | $1.51 | $1.35 | $1.44 | 1.49M |
| Oct 19, 2026 | $1.35 | $1.41 | $1.35 | $1.395 | 966.95K |
| Oct 16, 2026 | $1.43 | $1.4744 | $1.305 | $1.33 | 1.67M |
| Oct 15, 2026 | $1.44 | $1.485 | $1.42 | $1.455 | 1.11M |
| Oct 14, 2026 | $1.54 | $1.57 | $1.41 | $1.47 | 2.13M |
| Oct 13, 2026 | $1.65 | $1.68 | $1.53 | $1.57 | 1.6M |
| Oct 12, 2026 | $1.71 | $1.74 | $1.66 | $1.67 | 607.84K |
| Oct 9, 2026 | $1.65 | $1.75 | $1.635 | $1.74 | 1.39M |
| Oct 8, 2026 | $1.55 | $1.67 | $1.53 | $1.66 | 1.13M |
| Oct 7, 2026 | $1.56 | $1.60 | $1.55 | $1.57 | 832.19K |
| Oct 6, 2026 | $1.58 | $1.61 | $1.555 | $1.60 | 771.31K |
| Oct 5, 2026 | $1.69 | $1.735 | $1.58 | $1.58 | 985.94K |
Latest PROK news
The latest Smart Investors Daily articles mentioning PROK.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

